XT
WHWK

XTX Topco’s Whitehawk Therapeutics WHWK Stock Holding History

XTX Topco’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.8K Sell
18,522
-4,461
-19% -$18.6K ﹤0.01% 3574
2026
Q1 		$79.3K Buy
22,983
+7,279
+46% +$22.8K ﹤0.01% 3178
2025
Q4 		$38K Sell
15,704
-4,076
-21% -$9.35K ﹤0.01% 2898
2025
Q3 		$37.6K Buy
+19,780
New +$36.4K ﹤0.01% 2221
2025
Q1 		– Sell
-13,245
Closed -$41.8K – 3272
2024
Q4 		$41.8K Sell
13,245
-2,346
-15% -$5.31K ﹤0.01% 1928
2024
Q3 		$32.1K Buy
+15,591
New +$25.2K ﹤0.01% 1767
2024
Q2 		– Sell
-26,500
Closed -$62K – 2579
2024
Q1 		$62K Buy
26,500
+16,271
+159% +$31.4K 0.01% 1440
2023
Q4 		$20.7K Buy
+10,229
New +$42.9K ﹤0.01% 1356
2023
Q2 		– Sell
-12,078
Closed -$87.4K – 1924
2023
Q1 		$87.4K Sell
12,078
-2,151
-15% -$23K 0.02% 1116
2022
Q4 		$183K Buy
14,229
+3,923
+38% +$51.2K 0.04% 876
2022
Q3 		$146K Buy
+10,306
New +$135K 0.04% 871
2021
Q3 		– Sell
-1,155
Closed -$29K – 1121
2021
Q2 		$29K Buy
+1,155
New +$26.4K 0.01% 750

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's WHWK Position: Q2 2026 in Review

XTX Topco reduced its Whitehawk Therapeutics (WHWK) stake by 19% in Q2 2026, selling an estimated $18.6K and leaving 18,522 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3574.

XTX Topco first reported a position in WHWK in Q2 2021 and has held it in 12 quarters since. The position peaked at $183K in Q4 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • XTX Topco held 18,522 shares of Whitehawk Therapeutics worth $84.8K as of Q2 2026.
  • XTX Topco sold 4,461 Whitehawk Therapeutics shares in Q2 2026, an estimated $18.6K.
  • Whitehawk Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3574 holding.
  • XTX Topco first reported a position in Whitehawk Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • XTX Topco's Whitehawk Therapeutics position peaked at $183K in Q4 2022.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.